Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Abstract Introduction The risk of SARS-CoV-2 infection or severe coronavirus disease 2019 (COVID-19) has been shown to increase in patients with multiple sclerosis (MS). Vaccination is recommended in this patient population, and the effect of disease-modifying treatments (DMTs) on response to vaccin...

Full description

Bibliographic Details
Main Authors: Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, Ana Morales-Ortiz, José. E. Meca-Lallana
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-12-01
Series:Neurology and Therapy
Subjects:
COVID-19
Multiple sclerosis
SARS-CoV-2 vaccination
Serological response
Online Access:https://doi.org/10.1007/s40120-023-00572-8

Internet

https://doi.org/10.1007/s40120-023-00572-8

Similar Items